Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

LENZ Therapeutics (LENZ) Revenue (2025)

LENZ Therapeutics (LENZ) has disclosed Revenue for 1 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Revenue changed N/A to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $19.1 million for FY2025, N/A changed from the prior year.
  • Revenue for Q4 2025 was $1.6 million at LENZ Therapeutics, down from $12.5 million in the prior quarter.
  • The five-year high for Revenue was $12.5 million in Q3 2025, with the low at $1.6 million in Q4 2025.